Try our Advanced Search for more refined results

Citizens for Consume, et al v. Abbott Laboratories,, et al

Track this case

Case overview

Case Number:

1:01-cv-12257

Court:

Massachusetts

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Patti B. Saris

Firms

Companies

Government Agencies

Sectors & Industries:

  1. August 13, 2007

    AWP Defendants Pressure Judge To Rule On Damages

    Following a June ruling that AstraZeneca, Bristol-Myers Squibb and Schering-Plough Corp. had inflated average wholesale prices for drugs, the pharmaceutical companies have asked that final judgment regarding damages be rendered posthaste so they can file a swift appeal.

  2. August 07, 2007

    AstraZeneca Fights Damages In Drug Pricing Suit

    On the heels of a similar bid by Warrick Pharmaceuticals Corp., AstraZeneca Pharmaceuticals LP has rejected a request that it shell out treble damages to two classes in the average wholesale price litigation, arguing that such a remedy is unwarranted.

  3. August 06, 2007

    Warrick Fires Back Over Drug Pricing Damages

    Warrick Pharmaceuticals Corp. has taken issue with a request that it pay more than $8 million to a class in the average wholesale price litigation, arguing that the plaintiffs have not followed a judge's orders regarding calculating damages.

  4. August 03, 2007

    Plaintiffs Propose "Road Map" For Drug Pricing Suit

    The plaintiffs in the massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications have presented the court with a "road map" for how best to organize the complex litigation.

  5. August 01, 2007

    Judge Issues Mixed Ruling In Drug Pricing Suit

    A judge has handed down a mixed ruling in a massive antitrust case against a slew of drug companies accused of scamming Medicare, allowing in part and denying in part the defendants’ motion to toss claims that they artificially inflated prices for prescription drugs.

  6. July 31, 2007

    States Fight Mediation In Drug Pricing Suit

    The attorneys general of five states have lashed out at a federal judge’s order requesting certain parties to resolve their differences through mediation in a massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications.

  7. July 26, 2007

    Judge Orders Mediation In Drug Pricing Suit

    In a bid to bring some closure to a massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications, a federal judge has ordered certain parties in the case to resolve their differences through mediation.

  8. July 25, 2007

    States Bury Hatchet With TAP Over Drug Pricing

    In a boost for TAP Pharmaceutical Products Inc., the states of Montana and Nevada have asked a federal judge to sign off on a settlement that would toss the company from a massive antitrust class action alleging that a spate of drug makers defrauded consumers by artificially inflating the prices of various prescription medications.

  9. July 19, 2007

    Bristol-Myers Pays $13M To Settle Pricing Class Action

    Just days before a trial was set to start, Bristol-Myers Squibb has agreed to pay $13 million to settle a class action lawsuit brought by patients who said they paid too much for their drugs for a period of about six years.

  10. July 17, 2007

    Special Master OKs $70M Glaxo Settlement

    The $70 million proposed settlement with GlaxoSmithKline plc in an antitrust class action that alleged it defrauded consumers by artificially inflating the prices of various prescription drugs should be approved, the case's special settlement master concluded Monday.